Ticketmaster is planning for the return of live events in 2021. As a part of the ticketing giant’s new framework, Ticketmaster will require proof of a COVID-19 vaccination or a negative COVID test within a 24-72 hour window before allowing admission to an event.
Earlier this week, it was announced that Pfizer and BioNTech had developed a COVID-19 vaccine with a 90-percent trial success rate. The trial — which included over 43,000 participants of racially and ethnically diverse backgrounds — showed no serious side effects from the vaccine. Trial participants were given two doses, spaced 21 days apart, meaning the vaccine was effective within 28 days of the first dose, but Pfizer also noted “the final vaccine efficacy percentage may vary” as trials continue.